Nicox: Nicox, and Glaukos ink exclusive NCX 1728 research and global licensing option agreement
Nicox SA, an international ophthalmology company, announced that it has entered into an exclusive research and license option agreement with Glaukos Corporation for NCX 1728, Nicox's novel nitric oxide (NO)─
Read full article »
Nicox is a France-based ophthalmology company that discovers, and develops novel ophthalmic therapeutics for the treatment of eye diseases.
Read more